|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 50.98 USD | +0.31% |
|
-1.45% | +12.94% |
| Jun. 12 | PTC Therapeutics, Inc., Q1 2025 Earnings Call, May 06, 2025 | |
| Jun. 11 | UniQure N.V. Announces Appointment of Kylie O?Keefe as Chief Customer and Strategy Officer, Effective June 6, 2025 | CI |
| Capitalization | 4.04B 3.49B 3.29B 2.97B 5.5B 346B 6.2B 38.19B 14.91B 159B 15.16B 14.84B 581B | P/E ratio 2025 * |
9.52x | P/E ratio 2026 * | -21.2x |
|---|---|---|---|---|---|
| Enterprise value | 2.49B 2.15B 2.03B 1.83B 3.39B 213B 3.82B 23.53B 9.19B 97.97B 9.34B 9.14B 358B | EV / Sales 2025 * |
1.59x | EV / Sales 2026 * | 3x |
| Free-Float |
97.66% | Yield 2025 * |
-
| Yield 2026 * | - |
More valuation ratios
* Estimated data
More news
Last Transcript: PTC Therapeutics, Inc.
More recommendations
More press releases
More news
| 1 day | +0.31% | ||
| 1 week | -1.45% | ||
| Current month | +5.07% | ||
| 1 month | +10.80% | ||
| 3 months | -4.91% | ||
| 6 months | +7.64% | ||
| Current year | +12.94% |
| 1 week | 50.33 |  | 52.93 |
| 1 month | 44.04 | | 52.98 |
| Current year | 35.95 | | 58.38 |
| 1 year | 28.72 | | 58.38 |
| 3 years | 17.53 | | 59.84 |
| 5 years | 17.53 | | 70.82 |
| 10 years | 4.03 | | 70.82 |
| Manager | Title | Age | Since |
|---|---|---|---|
Matthew Klein
CEO | Chief Executive Officer | 53 | 2023-03-21 |
Pierre Gravier
DFI | Director of Finance/CFO | 40 | 2023-07-12 |
Lee Golden
CTO | Chief Tech/Sci/R&D Officer | 57 | 2021-12-31 |
| Director | Title | Age | Since |
|---|---|---|---|
| Chairman | 73 | 2004-10-31 | |
Allan Jacobson
BRD | Director/Board Member | 79 | 1998-03-30 |
David Southwell
BRD | Director/Board Member | 64 | 2005-11-30 |
| Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
|---|---|---|---|---|---|---|
| +0.31% | -1.45% | +35.33% | +90.22% | 4.03B | ||
| +0.42% | +6.05% | -6.37% | +173.40% | 726B | ||
| +0.90% | +1.95% | +7.74% | -9.21% | 374B | ||
| +0.48% | +8.92% | -47.13% | +32.18% | 353B | ||
| +0.48% | +2.64% | +15.85% | +34.37% | 338B | ||
| +1.00% | +2.02% | +12.83% | -13.17% | 264B | ||
| +1.10% | +2.11% | +4.24% | +16.86% | 232B | ||
| +1.14% | +2.45% | -10.88% | +11.97% | 229B | ||
| +1.87% | +5.41% | -37.16% | -6.15% | 202B | ||
| +1.88% | +3.55% | -1.26% | +23.87% | 157B | ||
| Average | +0.81% | +2.34% | -2.68% | +35.43% | 287.88B | |
| Weighted average by Cap. | +0.59% | +3.36% | -6.49% | +52.61% |
| 2025 * | 2026 * | |
|---|---|---|
| Net sales | 1.56B 1.35B 1.27B 1.15B 2.13B 134B 2.4B 14.76B 5.76B 61.45B 5.86B 5.74B 224B | 878M 759M 714M 646M 1.2B 75.21B 1.35B 8.3B 3.24B 34.55B 3.29B 3.23B 126B |
| Net income | 643M 556M 523M 474M 876M 55.09B 987M 6.08B 2.37B 25.31B 2.41B 2.36B 92.46B | -202M -175M -165M -149M -276M -17.34B -310M -1.91B -747M -7.96B -759M -743M -29.09B |
| Net Debt | -1.55B -1.34B -1.26B -1.14B -2.11B -133B -2.38B -14.65B -5.72B -61.01B -5.82B -5.69B -223B | -1.41B -1.21B -1.14B -1.03B -1.91B -120B -2.16B -13.28B -5.19B -55.3B -5.27B -5.16B -202B |
More financial data
* Estimated data
Employees
939
Sector
Pharmaceuticals
Calendar
Jun. 17
- Annual General Meeting
| Date | Price | Change | Volume |
|---|---|---|---|
| 25-06-12 | 50.98 $ | +0.31% | 597,604 |
| 25-06-11 | 50.82 $ | -1.78% | 608,839 |
| 25-06-10 | 51.74 $ | +0.10% | 827,719 |
| 25-06-09 | 51.69 $ | -0.84% | 967,121 |
| 25-06-06 | 52.13 $ | +0.77% | 936,061 |
Delayed Quote Nasdaq, June 12, 2025 at 04:00 pm EDT
More quotes
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
16
Last Close Price
50.98USD
Average target price
61.67USD
Spread / Average Target
+20.96%
Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- PTCT Stock
Select your edition
All financial news and data tailored to specific country editions
